This analysis reveals how TREM2+ macrophages contribute to inflammation in peripheral artery disease among diabetes patients, suggesting new therapeutic targets.
Reprogrammed TREM2 + macrophages drive nonresolving inflammation in peripheral artery disease associated with type 2 diabetes (Malhi et al. , this issue).
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: